Cristiana Sieiro Santos, Jun-Peng Chen, Elena Nikiphorou, Chi-Wei Tseng, Carlos Enrique Toro Gutiérrez, Ai Lyn Tan, Arvind Nune, Esha Kadam, Masataka Kuwana, Jessica Day, Sreoshy Saha, Tsvetelina Velikova, James B Lilleker, Carlo V Caballero-Uribe, Parikshit Sen, Hector Chinoy, Rohit Aggarwal, Vikas Agarwal, Latika Gupta, Yi-Ming Chen
COVID-19 has been suggested as a possible trigger of disease flares in patients with rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown. This study aimed to identify factors associated with breakthrough infection (BIs) and disease flares in patients with RA following COVID-19. We analysed data from RA patients who participated in the COVID-19 vaccination in autoimmune diseases (COVAD) study. Demographic data, patient-reported outcomes, comorbidities, pharmacologic treatment and details regarding disease flares were extracted from the COVAD database...
March 12, 2024: Rheumatology International